In fact, preclinical studies in mouse models have shown that inhibition or blockade of CD47 inhibits tumor growth and enables the phagocytosis and killing of tumor cells by macrophages in several types of tumors, including ovarian, endometrial, liver, and squamous cell lung cancer, respectively [164,165,166,167,168]. Here, CD47 is linked to neoplasm.